Silvia Pietrobono

11PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsSolid tumoursGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 13, 2026
EGFR ligand Angiogenin predicts response to ALK5 inhibition in pancreatic cancer via a TNF-α paracrine axis in tumor-associated macrophages.

Silvia Pietrobono, Veronica De Vita, Domenico Mangiameli

|Sep 22, 2023
Autotaxin Secretion Is a Stromal Mechanism of Adaptive Resistance to TGFβ Inhibition in Pancreatic Ductal Adenocarcinoma.

Silvia Pietrobono, Fabio Sabbadini, Monica Bertolini

|Mar 29, 2023
Targeting FGFR Pathway Is Not an Effective Therapeutic Strategy in Patients with Unselected Metastatic Esophagogastric Cancer Resistant to Trastuzumab.

Camilla Zecchetto, Alberto Quinzii, Simona Casalino

|Jan 10, 2022
Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion.

Marina Gaule, Camilla Pesoni, Alberto Quinzii

|Oct 13, 2021
MAPK15 Controls Hedgehog Signaling in Medulloblastoma Cells by Regulating Primary Ciliogenesis.

Silvia Pietrobono, Lorenzo Franci, Francesco Imperatore

|Aug 27, 2021
The Role of Glycosylation in Melanoma Progression.

Chiara De Vellis, Silvia Pietrobono, Barbara Stecca

Pageof 2

Frequent Collaborators

5 joint publications

Barbara Stecca

4 joint publications

Davide Melisi

3 joint publications

Valeria Merz

2 joint publications

Simona Casalino